Capital (CAPD) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
15 Oct, 2026Executive summary
Q3 2026 revenue was $115.7m, up 23.2% YoY; nine-month revenue reached $334.7m, up 32.2% YoY.
2026 revenue guidance increased to $435–$455m, including MDU revenue consolidated from 30 September; growth plans include Belinga expansion and entry into Australia.
Financial highlights
Q3 revenue was $115.7m, up 23.2% YoY and down 1.4% QoQ.
Drilling and associated revenue was $64.5m, down 0.9% YoY and 5.1% QoQ; mining revenue was $25.2m, up 223.1% YoY and down 1.2% QoQ.
MSALABS revenue was $26.0m, up 23.8% YoY and 9.2% QoQ.
Outlook and guidance
2026 revenue guidance raised to $435–$455m, from $430–$450m at H1 and $410–$440m initially; MSALABS guidance reiterated at $85–$95m.
Capex guidance reiterated at $55–$65m; focus includes integrating MDU and mobilising with Fortescue and Maaden.
Two further laboratories are expected to be commissioned, with expansion continuing at several existing laboratories.
Latest events from Capital
- 2023 growth and Tier 1 wins underpin a $355m-$375m revenue target for 2024.CAPD
H2 2023 - Revenue up 37.6% and guidance raised, driven by strong contracts and MSALABS growth.CAPD
H1 2026 - Record Q2 revenue and strong outlook, with growth across all divisions and new contracts.CAPD
Q2 2026 TU - Record revenue, 2026 guidance, lab expansion, and strategic growth amid strong demand.CAPD
AGM 2026 - Record Q1 revenue and new contracts drive strong 2026 outlook despite portfolio volatility.CAPD
Q1 2026 TU - NPAT up 317.6% on investment gains, with 2026 revenue guidance at $410–440m and strong demand.CAPD
H2 2025 - Revenue up 9.8%, margins down; growth expected from new contracts and US expansion.CAPD
H1 2024 - 2024 revenue guidance is $355–$375 million, with key resolutions and growth across business pillars.CAPD
AGM 2024 - Record 2024 revenue, with 2025 growth expected as Reko Diq and MSALABS ramp up.CAPD
H2 2024